Processa Pharmaceuticals, Inc. Preferred Stock, Shares Authorized
Processa Pharmaceuticals, Inc. (PCSA) had Preferred Stock, Shares Authorized of 1.00 million shares as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesAuthorized · last filed 2026-08-14
- 2026-06-30: Preferred Stock, Shares Authorized 1.00M shares.
- 2026-03-31: Preferred Stock, Shares Authorized 1.00M shares.
- 2025-12-31: Preferred Stock, Shares Authorized 1.00M shares.
- 2025-09-30: Preferred Stock, Shares Authorized 1.00M shares.
| Period end | Preferred Stock, Shares Authorized | Preferred Stock, Shares Authorized as first filed |
|---|---|---|
| 2026-06-30 | 1.00M shares 10-Q · filed 2026-08-14 | |
| 2026-03-31 | 1.00M shares 10-Q · filed 2026-05-07 | |
| 2025-12-31 | 1.00M shares 10-Q · filed 2026-08-14 | |
| 2025-09-30 | 1.00M shares 10-Q · filed 2025-11-06 | |
| 2025-06-30 | 1.00M shares 10-Q · filed 2025-08-07 | |
| 2025-03-31 | 1.00M shares 10-Q · filed 2025-05-08 | |
| 2024-12-31 | 1.00M shares 10-K · filed 2026-03-18 | |
| 2023-12-31 | 1.00M shares 10-K · filed 2025-03-20 | |
| 2019-12-31 | 1.00M shares 10-K · filed 2020-03-06 | |
| 2019-09-30 | 1.00M shares 10-Q · filed 2019-11-14 | |
| 2019-08-31 | 10.00M shares 10-K · filed 2020-03-06 | |
| 2019-06-30 | 10.00M shares 10-Q · filed 2019-08-14 | |
| 2019-03-31 | 10.00M shares 10-Q · filed 2019-05-14 | |
| 2018-12-31 | 10.00M shares 10-Q · filed 2019-11-14 | |
| 2018-09-30 | 10.00M shares 10-Q · filed 2018-11-14 | |
| 2018-06-30 | 10.00M shares 10-Q · filed 2018-08-14 | |
| 2018-03-31 | 10.00M shares 10-Q · filed 2018-05-21 | |
| 2017-12-31 | 10.00M shares 10-K/A · filed 2019-04-08 | |
| 2017-09-30 | 10.00M shares 10-Q · filed 2017-11-20 | |
| 2017-06-30 | 4.50M shares 10-Q · filed 2017-10-04 | |
| 2017-03-31 | 4.50M shares 10-Q · filed 2017-10-04 | |
| 2016-12-31 | 10.00M shares 10-K · filed 2018-04-16 | 4.50M shares 10-K · filed 2017-09-25 |
| 2016-09-30 | 4.50M shares 10-Q · filed 2017-09-08 | |
| 2016-06-30 | 4.50M shares 10-Q · filed 2017-08-30 | |
| 2016-03-31 | 4.50M shares 10-Q · filed 2017-08-07 | |
| 2015-12-31 | 4.50M shares 10-K · filed 2017-09-25 | |
| 2015-09-30 | 4.50M shares 10-Q · filed 2015-12-01 | |
| 2015-06-30 | 4.50M shares 10-Q · filed 2015-08-19 | |
| 2015-03-31 | 4.50M shares 10-Q · filed 2015-05-15 | |
| 2014-12-31 | 4.50M shares 10-K · filed 2017-06-19 | |
| 2014-09-30 | 4.50M shares 10-Q · filed 2014-11-13 | |
| 2014-06-30 | 4.50M shares 10-Q · filed 2014-08-19 | |
| 2014-03-31 | 4.50M shares 10-Q · filed 2014-05-14 | |
| 2013-12-31 | 4.50M shares 10-K · filed 2015-04-14 | |
| 2013-09-30 | 4.50M shares 10-Q · filed 2013-11-08 | |
| 2013-06-30 | 4.50M shares 10-Q · filed 2013-11-08 | |
| 2012-12-31 | 3.00M shares 10-K · filed 2014-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |